# Trauma Glycemic Control Protocol

**Division of Acute Care Surgery**

---

## 1. Initial Glycemic Assessment

### Is the patient a known diabetic?

- **No:**
  - If blood glucose (BG) ≤ 150 mg/dL → **No further action**
  - If BG > 150 mg/dL:
    - **Check hemoglobin A1c (HbA1c)**
    - **Initiate correctional insulin using a sliding scale (SSI)**
    - If HbA1c > 6.5%:
      - Add **type 2 diabetes mellitus (T2DM)** to the problem list
      - Initiate **basal insulin**: Glargine **0.15 units/kg/day**
      - **Consult Endocrinology**

- **Yes (Established diabetes):**  
  Proceed to Section 2.

---

## 2. Management in Known Diabetics

### A. **Insulin-Dependent Diabetes Mellitus (IDDM)**

- Check **HbA1c**
- Initiate:
  - **Sliding Scale Insulin (SSI)**
  - **Basal insulin**: Resume **50% of home Glargine dose**
- If BG > 200 mg/dL:
  - If HbA1c > 6.5%:
    - Confirm diagnosis on problem list (if not already present)
    - Increase Glargine to **0.15 units/kg/day**
    - **Consult Endocrinology**

### B. **Non–Insulin-Dependent Diabetes Mellitus (NIDDM)**

- Check **HbA1c**
- Initiate:
  - **Sliding Scale Insulin (SSI)**
  - **Basal insulin**: Glargine **0.15 units/kg/day**

---

## 3. Persistent Hyperglycemia

> **If BG remains > 180 mg/dL despite SSI and basal insulin:**

- **Add prandial insulin (Lispro)** with meals  
  *or*  
- **Initiate scheduled Lispro q4–6h** in patients receiving continuous enteral nutrition

---

## 4. General Principles and Safety Considerations

- **Avoid SSI monotherapy** in type 2 diabetes mellitus (T2DM)  
- **Continue basal insulin** even if the patient is NPO  
- Ensure the **hypoglycemia protocol** is activated with all insulin orders  
- **Endocrinology consultation is recommended for:**
  - Type 1 diabetes mellitus (T1DM)
  - Patients using insulin pumps
  - Newly diagnosed T2DM (HbA1c > 6.5%)
  - Known diabetics with HbA1c > 9%

### Use caution in:

- Patients with chronic kidney disease (CKD)  
- Older adults  
- Patients with significant fluid shifts  
  - **Consider pharmacy consultation** in these cases

---

## 5. Discontinuation of Glycemic Monitoring

**Consider stopping BG checks and insulin therapy if ALL criteria are met:**

- BG remains **≤ 150 mg/dL**  
- Patient has met **tube feeding goal for > 24 hours**  
- Patient is **off vasopressors**

---

# Insulin Infusion Protocol (TICU Only)

---

## 6. Initiation Criteria

> **Consider initiating an insulin infusion per TICU protocol if:**

- **Two consecutive BG readings ≥ 250 mg/dL**

### Nutritional Support Required

Ensure a **glucose source** is provided via one of the following:

- **D10** infusion at 30 mL/hr  
- **D5LR** or **D5NS** at ≥ 50 mL/hr  
- **Enteral nutrition** at ≥ 50% of target goal rate  
- **Parenteral nutrition** (PN) infusing

---

## 7. Transition Off Insulin Infusion

**When to discontinue insulin infusion:**

- Infusion rate is **≤ 5 units/hr** for ≥ 4 hours  
- Patient is receiving a **consistent source of nutrition**

**Transition strategy:**

1. Discontinue insulin infusion  
2. Initiate **Sliding Scale Insulin** per Burn/Trauma order set  
3. Calculate total insulin administered over the past 24 hours  
4. Administer **70% of that total daily dose**:
   - **50% as basal insulin (e.g., Glargine)**
   - Continue SSI  
   - **Add prandial insulin (Lispro)** q4–6h or with meals if needed

---

## 8. References

1. Yendamuri S, et al. *Admission hyperglycemia as a prognostic indicator in trauma.* J Trauma. 2003; 55:33–38.  
2. Laird A, et al. *Relationship of early hyperglycemia to mortality in trauma patients.* J Trauma. 2004; 56:1058–1062.  
3. Sung J, et al. *Admission hyperglycemia is predictive of outcome in critically ill trauma patients.* J Trauma. 2005; 59:80–83.  
4. Van den Berghe G, et al. *Intensive insulin therapy in critically ill patients.* N Engl J Med. 2001; 345:1359–1367.  
5. NICE-SUGAR Study Investigators. *Intensive vs. conventional glucose control in critically ill patients.* N Engl J Med. 2009; 360:1283–1297.  
6. Jacobi J, et al. *Guidelines for the use of insulin infusion in critically ill patients.* Crit Care Med. 2012; 40:3251–3276.  
7. Mowery NT, et al. *Severe hypoglycemia is not an independent predictor of death after trauma.* J Trauma. 2010; 68:342–347.  
8. Mowery NT, et al. *Duration of intensive insulin therapy predicts hypoglycemia.* World J Surg. 2011; 36:270–277.  
9. Krinsley J, et al. *Glycemic variability as a predictor of mortality in critically ill patients.* Crit Care Med. 2008; 36:3008–3013.  
10. Kauffmann RM, et al. *Balanced nutrition protects against hypoglycemia in surgical ICU patients.* JPEN. 2011; 35:686–694.  
11. Bode BW, et al. *IV insulin infusion: indications, methods, and transition to subQ insulin.* Endocr Pract. 2004; 10(2):71–80.

---

## 9. Revision History

- **January 2020**  
- **March 2023**

---

## 10. Revision Team

- Michael Derickson, MD  
- Jill Streams, MD — Trauma PI Director  
- Bradley Dennis, MD — Trauma Medical Director  
- Caroline Banes, DNP, ACNP-BC  
- Kayla Harding, MSN, AGACNP  
- Leanne Atchison, PharmD
